Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Gross Profit Margin (Quarterly) : 66.20% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 66.20% |
| June 30, 2026 | 68.10% |
| March 31, 2026 | 65.39% |
| December 31, 2025 | 75.43% |
| September 30, 2025 | 68.03% |
| June 30, 2025 | 62.67% |
| Date | Value |
|---|---|
| March 31, 2025 | 47.19% |
| December 31, 2024 | 54.42% |
| September 30, 2024 | 43.70% |
| June 30, 2024 | 37.54% |
| March 31, 2024 | 32.37% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Natera, Inc. | 63.95% |
| Myriad Genetics, Inc. | 64.04% |
| BioRestorative Therapies, Inc. | -157.8% |
| CareDx, Inc. | 70.51% |
| Exagen, Inc. | 58.84% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.67% |
| Return on Assets | 8.34% |
| Return on Invested Capital | 9.45% |
| Profit Margin (Quarterly) | 5.54% |
| Operating Margin (Quarterly) | 7.01% |
| Return on Net Operating Assets | 30.49% |